We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US May Require Subject Consent for Clinical Trials Listing
US May Require Subject Consent for Clinical Trials Listing
January 14, 2010
A rule proposed by the U.S. Food and Drug Administration (FDA) requires that informed consent forms for clinical trials include specific language telling
patients that registration, results and other information about the trial will be submitted to ClinicalTrials.gov, a publicly available trial registry
database.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor